Form 4: T2 Biosystems Director Awarded 25,000 Restricted Stock Units

T2 Biosystems director David B. Elsbree was granted 25,000 restricted stock units (RSUs) that vest in two equal annual installments starting November 4, 2025.

Summary

• David B. Elsbree, a director at T2 Biosystems, was granted 25,000 restricted stock units (RSUs) on November 4, 2024.
• These RSUs will vest in two equal annual installments, beginning on November 4, 2025.
• The grant was contingent on stockholder approval of the amendment and restatement of the Issuer's 2014 Incentive Award Plan.
• The stockholders approved the amendment on December 30, 2024.
• Each RSU represents a contingent right to receive one share of T2 Biosystems common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock-based compensation to directors, which is generally viewed positively as it aligns interests with shareholders. There are no negative implications or surprises.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The RSUs will vest in two equal annual installments beginning on November 4, 2025, contingent on continued service.

Industry Context

The granting of stock-based compensation to directors is a common practice in publicly traded companies to align their interests with those of shareholders and incentivize performance.

Comparison to Industry Standards

• Stock-based compensation, such as RSUs, is a standard practice for compensating directors in publicly traded companies.
• The vesting schedule of two equal annual installments is a typical approach to ensure long-term commitment.
• Companies like Exact Sciences, Bio-Rad Laboratories, and QuidelOrtho also use stock-based compensation for their directors, with similar vesting schedules.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term performance.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Restricted Stock Units, RSU, Stock Grant, Director Compensation, Incentive Award Plan, T2 Biosystems, TTOO